Poland· PL-100492518
Belara
A chlormadinon und ethinylestradiol product containing ethinylestradiolum + chlormadinoni acetas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Chlormadinon und ethinylestradiol is registered in 4 of 19 countries.
Countries holding a registration under ATC G03AA15 (chlormadinon und ethinylestradiol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Chlormadinon und ethinylestradiol · ATC G03AA15
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Ethinylestradiolum + Chlormadinoni acetas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03AA15
- ATC class
- Chlormadinon und Ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991529543
- gtin05909991529550
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for chlormadinon und ethinylestradiol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlormadinon und ethinylestradiol · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Chlormadinon und ethinylestradiol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBELARAGedeon Richter Plc., Budapešť
- GermanyAmelinaBiomo Pharma Gmbh
- SwitzerlandBelara, FilmtablettenGedeon Richter (Schweiz) AG
- SpainBALIANCA 2 mg/0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULAGedeon Richter Plc.
- FranceBELARA 0,03 mg/2 mg, comprimé pelliculéGEDEON RICHTER ( HONGRIE)
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Balanca, Belara
- Belgium · Bellina, Helen
- Czechia · Belara, Clormetin
- Germany · Amelina, Angiletta
- Estonia · Clormetin
- Spain · Belara, Clormadinona/Etinilestradiol Stadafarma
- France · Belara
- Greece · Labous
- Croatia · Belara, Estal
- Hungary · Belara
- Italy · Belara, Eve
- Lithuania · Belara
- Luxembourg · Bellina, Bellissima
- Latvia · Belara, Clormetin
- Portugal · Belara, Chariva
- Romania · Belara
- Slovenia · Belara
- Slovakia · Belara, Lydely
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e4f9f4e-0ec7-4409-8b0f-5aacd1fb773a GET /v1/drugs/2e4f9f4e-0ec7-4409-8b0f-5aacd1fb773a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "0,03 mg + 2 mg",
"packaging": "05909991529543 ¦ Rp ¦ 152931\n21 tabl.\n05909991529550 ¦ Rp ¦ 152932\n63 tabl.",
"substance": "Ethinylestradiolum 0.03 mg + Chlormadinoni acetas 2 mg",
"common_name": "Ethinylestradiolum + Chlormadinoni acetas",
"pl_product_id": "100492518",
"pozwolenie_nr": "023/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-01-16"
}See everything about chlormadinon und ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.